Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Michel Ducreux(Université Paris-Saclay), Dirk Arnold(Asklepios Klinik Altona), Jean‐Luc Van Laethem(Deventer Ziekenhuis), Pascal Burtin(Institut Gustave Roussy), Diane Goèré(Assistance Publique – Hôpitaux de Paris), Karin Haustermans(Radboud University Nijmegen), Thomas Seufferlein(Universität Ulm), Caroline Caramella(Institut Gustave Roussy), Antoine Hollebecque(Institut Gustave Roussy), Thierry Conroy(Inserm)
Cited by 1,316
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k